subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage,
Conditions
Interventions
To evaluate cognitive function improvement effect of combined formulation of plasmalogens and elastin containing food for forgetful and dementia preliminary forces
Sponsors
Ono Ken
Yamada Shizuo
Sansho Pharmaceutical Co., Ltd.
HAGOROMO FOOS CORPORATION.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The subjects who are Male and Femaile over 65 who are aware of forgetfulness. 2) The subjects who displayed 24 scores or more of MMSE-J
Exclusion criteria
Exclusion criteria: 1) The subjects who are likely to have allergy symptoms due to test ingredients. 2) The subjects who were diagnosed as patients with dementia 3) The subjects who received surgical operation for stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, cerebral contusion injury Head trauma Those with the inpatient surgery. 4) The subjects with medical history of epilepsy or diabetes and/or receiving medical treatment presently. 5) The subjects who is taking medicines (antipsychotic drugs, anxiolytics, antidepressants, antiparkinsonian drugs, antidepressants, antiepileptic drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Japanese version of River Mead Behavior Memory Test | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Assessment for Attention-Visual Cancellation Task, MOS 36-Item Short-Form Health Survey, AGE Reader-Advanced Glycation End-products, | — |
Contacts
Public ContactShizuo Yamada
Center for Pharma-Food Research , Graduate School of Pharmaceutical Sciences, University of Shizuoka
Outcome results
None listed